# EDGAR Filing Document

**Accession Number:** 0001777921
**File Stem:** 0001437749-25-032058
**Filing Date:** 2025-10
**Character Count:** 8422
**Document Hash:** caf8ba4786bee14b88d988c5a50d9c9c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-032058.hdr.sgml**: 20251028

**ACCESSION NUMBER**: 0001437749-25-032058

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251028

**DATE AS OF CHANGE**: 20251028

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AvePoint, Inc.
- **CENTRAL INDEX KEY:** 0001777921
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 834461709
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91137
- **FILM NUMBER:** 251426598

**BUSINESS ADDRESS:**
- **STREET 1:** 525 WASHINGTON BLVD
- **STREET 2:** SUITE 1400
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07310
- **BUSINESS PHONE:** (201) 793-1111

**MAIL ADDRESS:**
- **STREET 1:** 525 WASHINGTON BLVD
- **STREET 2:** SUITE 1400
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07310

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Apex Technology Acquisition Corp
- **DATE OF NAME CHANGE:** 20190528
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lu Zhijian
- **CENTRAL INDEX KEY:** 0001874612

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** C/O AVEPOINT, INC.
- **STREET 2:** 525 WASHINGTON BLVD, SUITE 1400
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07310

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**AvePoint, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**053604104**

*(CUSIP Number)*

**Zhijian Lu**<br>c/o AvePoint, Inc.<br>525 Washington Blvd, Suite 1400<br>Jersey City NJ 07310<br>(804) 314-5903

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/24/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **053604104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Lu Zhijian** | Name of reporting person<br>**Lu Zhijian** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1405165.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**10275850.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1405165.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**10275850.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**11681015.00** | Aggregate amount beneficially owned by each reporting person<br>**11681015.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.5%** | Percent of class represented by amount in Row (11)<br>**5.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1)	Consists of (i) 131,526 shares held by the Reporting Person, (ii) 1,608,724 shares held by The Bridge Water Trust, (iii) 2,204,056 shares held by Fire Stone Family Trust, (iv) 4,854,346 shares held by KEM Phoenix, (v) 1,608,724 shares held by The Cherry Tree Trust, and (vi) 1,273,639 shares of common stock underlying options exercisable within 60 days of October 28, 2025. The Reporting Person has sole voting and dispositive power with respect to the shares held in his name and shares underlying options. The Reporting Person shares voting and dispositive power with Yan Ji with respect to shares held by Fire Stone Family Trust and KEM Phoenix. The Reporting Person shares voting and dispositive power with Jeffrey Scott Bardsley with respect to shares held by The Bridge Water Trust. Yan Ji shares voting and dispositive power with Wen Ji Bardsley with respect to shares held by The Cherry Tree Trust.

(2)	This percentage is calculated based upon 211,138,994 shares of Common Stock outstanding as of June 30, 2025, as disclosed by the Company in its 424(b)(5) filed with the Securities and Exchange Commission on September 16, 2025.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
AvePoint, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
525 WASHINGTON BLVD, SUITE 1400, JERSEY CITY, NJ, 07310

This Amendment No. 1 amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission on July 1, 2021 (the "Schedule 13D") by the Reporting Person (as previously defined in the initial Schedule 13D) with respect to shares of Common Stock, par value $0.0001 per share ("Common Stock"), of AvePoint, Inc., a Delaware corporation (the "Company"). Unless otherwise defined herein, capitalized terms used in this Amendment No. 1 shall have the meanings ascribed to them in the Schedule 13D. Unless amended or supplemented below, the information in the Schedule 13D remains unchanged.

**Item 4. Purpose of Transaction**

Item 4 is hereby amended by adding the following:

Secondary Offering

On September 16, 2025, in connection with a registered secondary public offering (the "Secondary Offering") of Common Stock, the selling security holders (the "Selling Securityholders"), including the Reporting Person, entered into an underwriting agreement (the "Underwriting Agreement") with the Company Jefferies LLC, Morgan Stanley & Co. LLC, Oversea-Chinese Banking Corporation Limited and UBS Securities, LLC, as representatives of the several underwriters named on therein (collectively, the "Underwriters"). In connection with the Secondary Offering, which closed on September 18, 2025, the Reporting Person sold 7,006,428 shares of Common Stock to the Underwriters at a purchase price of approximately $15.21 per share. Under the terms of the Underwriting Agreement, the Reporting Person granted the Underwriters an option exercisable for 30 days to purchase up to an additional 1,993,550 shares of the Common Stock at the public offering price, less underwriting discounts and commission (the "Over-Allotment Option"). On October 24, 2025, the Underwriters exercised the Over-Allotment Option and purchased an additional 1,319,130 shares of Common Stock from the Reporting Person.

The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the actual terms of such document, a copy of which is attached as an exhibit hereto and incorporated herein by reference. The terms of the Secondary Offering are further described in the Form 8-K filed by the Company with the Securities and Exchange Commission on September 16, 2025.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 is hereby amended by adding the following:

The description of the Underwriting Agreement included in Item 4 above is incorporated by reference into this Item 6.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Lu Zhijian

**Signature:** /s/ Zhijian Lu

**Name/Title:** Zhijian Lu

**Date:** 10/28/2025